Jeff is the Chief Operating Officer (COO) at Catalytic Life Sciences, a boutique firm that specializes in fundraising and M&A for private biotechnology companies. With 25 years in the biopharmaceutical industry, he brings a unique combination of strategic and operational experiences. After earning his MBA from the Boston University Questrom School of Business, he embarked on a career that has spanned large, mid-size, and small companies such as Eli Lilly, Boehringer Ingelheim, Merck Serono, Alexion, and Alnylam. Adaptable and diverse, he has worked in over 20 countries, and lived abroad for 25% of his career. He has held leadership positions in general management, marketing & sales, and international corporate strategy, across therapeutic areas spanning rare diseases, oncology, primary care, and specialty care. Jeff leads the advisory board at Nami Therapeutics and is a former member of the board of directors at BIOTECanada.